Newsroom

RICHMOND, Va.--(BUSINESS WIRE)--Dominion Energy, Inc. (NYSE: D), today announced unaudited net income determined in accordance with Generally Accepted Accounting Principles (GAAP, or reported earnings) for the three months ended Sept. 30, 2026, of $1.2 billion ($1.30 per share) compared with net income of $1.0 billion ($1.16 per share) for the same period in 2025. Operating earnings (non-GAAP) for the three months ended Sept. 30, 2026, were $1.1 billion ($1.28 per share), compared to operating...

SWORDS, Ireland--(BUSINESS WIRE)--Trane Technologies (NYSE: TT), a global climate innovator, brings together engineers, innovators and industry leaders for bold conversations at the forefront of sustainable technology in Season 6 of the Healthy Spaces Podcast. Co-hosted by Trane Technologies leaders Scott Tew, Vice President and Global Head of Sustainability Strategy, and Dominique Silva, Marketing Leader for Europe, Middle East and Africa, this season explores the pivotal moment when breakthro...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for varegacestat, an investigational, oral, once-daily gamma secretase inhibitor (GSI), for the treatment of adults with desmoid tumors. Validation confirms that the application is complete,...

WALTHAM, Mass.--(BUSINESS WIRE)--Pretzel Therapeutics, Inc., a clinical-stage biotechnology company advancing a new class of medicines designed to restore mitochondrial function, improve cellular energetics and impede disease progression across a range of neurological and rare diseases, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the company’s clinical trial application for PX578, the company’s lead therapeutic candidate being developed for...

ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII) (“LCI”), today announced that its Board of Directors, in consultation with its outside financial and legal advisors, has unanimously determined that the unsolicited, non-binding proposal received from Monomoy Capital Partners to acquire LCI for $101 per share in cash does not constitute a superior proposal and is not reasonably likely to lead to a superior proposal. In reviewing Monomoy’s proposal, the Board of Directors carefully cons...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 29.10.2026 GRDU.LN IE000J80JTL1 46,075,002.00 USD 2,729,295,222.04 59.236  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 29.10.2026 LANDXEN.LN IE000C75IMX8 15,878.00 USD 310,784.57 19.573  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 29.10.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 741,830.02 21.796  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 29.10.2026 FPX. IE00BYTH6238  225,002.00 USD  14,598,315.15   64.881  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 29.10.2026 FGBL.LN IE00BYTH6121  464,196.00 USD  46,482,751.58  100.136  ...